Quantum-Si to Report First Quarter 2023 Financial Results on May 11, 2023

GUILFORD, Conn.–(BUSINESS WIRE)–Apr. 20, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will report financial results for the first quarter 2023 on Thursday, May 11, 2023. Company management will host a conference call to discuss financial results and provide a business update on the same […]

Quantum-Si To Present Poster on Single-Molecule Method for Detection of Arginine Post-Translational Modifications at the AACR Annual Meeting 2023

GUILFORD, Conn.–(BUSINESS WIRE)–Apr. 14, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced it will be presenting a poster on a new method for detection of arginine post-translational modifications (PTMs) using Platinum™, the world’s first next-generation single-molecule protein sequencing platform, at the American Association for Cancer Research’s (AACR) […]

Quantum-Si to Participate in B. Riley Securities’ Life Sciences Tools Conference – Proteomics Setting the Blueprint for Innovative Drug Creation, Virtual Conference

GUILFORD, Conn.–(BUSINESS WIRE)–Mar. 24, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will be participating in B. Riley Securities’ Life Sciences Tools Conference – Proteomics Setting the Blueprint for Innovative Drug Creation, Virtual Conference to be held on Thursday, April 6, 2023. Patrick Schneider, Ph.D., […]

Quantum-Si Reports Fourth Quarter and Fiscal Year 2022 Financial Results

The Company began shipments of Platinum™ instruments and expects to book revenue in Q1 2023 The Company projects an extended cash runway into 2026 GUILFORD, Conn.–(BUSINESS WIRE)– March 6, 2023–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced financial results for the fourth quarter and fiscal year ended December […]

Quantum-Si to Participate in the 43rd Annual Cowen Health Care Conference

GUILFORD, Conn.–(BUSINESS WIRE)–Feb. 17, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will be participating in the 43rd Annual Cowen Health Care Conference taking place at the Boston Marriott Copley Place, Boston, MA on March 6-8, 2023. Quantum-Si’s management will present on Tuesday, March 7, […]

Quantum-Si to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023

GUILFORD, Conn.–(BUSINESS WIRE)–Feb. 13, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will report financial results for the fourth quarter and full year 2022 before market open on Monday, March 6, 2023. Company management will host a conference call to discuss financial results and provide […]

Quantum-Si and Aviva Systems Biology Partner to Co-Develop Sample Preparation Kits for Protein Sequencing

Protein Enrichment Kits to Enable Deep Interrogation of Proteoforms through Protein Sequencing GUILFORD, Conn.–(BUSINESS WIRE)–Jan. 9, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it entered into a partnership with Aviva Systems Biology, a leading provider of antibody, protein, and immunoassay reagent products with an extensive […]

Quantum-Si and Biovista Partner to Provide AI-Driven Deep Proteomics Insights from the Platinum™ Next-Generation Protein Sequence Platform Output

Partnership Joins Protein Sequencing Technology With AI Visualization to Further Unlock the Human Proteome for Novel Drug Discovery Key Takeaways This partnership combines Quantum-Si’s expertise in single molecule protein sequencing with Biovista’s AI visualization technology to facilitate faster and more efficient protein drug target discovery. GUILFORD, Conn.–(BUSINESS WIRE)–Jan. 9, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” […]

Quantum-Si Begins Commercial Shipments of the PlatinumTM Protein Sequencing System and Provides Business Updates at the 41st Annual J.P. Morgan Healthcare Conference

Company Announces Commercial Shipments of Protein Sequencing System, Reveals New Partnerships, and Reaffirms Commitment to Financial Discipline Launched in December 2022, Platinum is the First Commercially Available Next-Generation Single-Molecule Protein Sequencing System Looking to Unlock the Proteome One Amino Acid at a Time GUILFORD, Conn.–(BUSINESS WIRE)–Jan. 9, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or […]

Quantum-Si to Participate in the 41st Annual J.P. Morgan Healthcare Conference

GUILFORD, Conn.–(BUSINESS WIRE)– Dec. 22, 2022–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will be participating in the 41st Annual J.P. Morgan Healthcare Conference taking place at the Westin St. Francis, San Francisco, CA on January 9-12, 2023. Quantum-Si’s management will present on Thursday, January 12 […]